Snowball logo
logo
IVBU

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF

IVBUF • PINK
$6.112+$0.1195  (1.99%)
About the company
Ticker
IVBUF
ISIN
Country
Other
Sector (GICS)
Other
iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the biotechnology and pharmaceuticals sector. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the NASDAQ Biotechnology Index, by employing representative sampling methodology. iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF was formed on October 19, 2017 and is domiciled in Ireland.

Frequently asked questions

What is iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF (IVBUF) current stock price?

As of the latest data, iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF stock price is $6.11, with a previous close of $5.99. iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF gained $0.12 in the last trading session, representing a 1.99% increase.

Does iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF (IVBUF) pay dividends?

No. iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF does not pay a dividend.